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ABSTRACT  
Objective: To development and validation of a stability indicating reverse phase HPLC (RP-HPLC) method for the analysis of griseofulvin, an 
antifungal drug, and its assay method, in tablet dosage forms.  
Methods: The proposed RP-HPLC method utilizes Shiseido C18, 250 mm × 4.6 mm i.d., 5μ column (at ambient temperature), isocratic run [using 
Methanol and Water (70:30) as mobile phase], at a flow rate of 1.0 ml/minute, and UV detection at 291 nm for analysis of griseofulvin. This method 
was selected after applying different chromatographic conditions, the chromatographic variables like flow rate, the composition of mobile phase 
and nature of stationary phase were studied. 
Results: The reported method is linear over the range of 0.1-1.2μg/ml with a coefficient of correlation (r2
Conclusion: An economical, accurate, sensitive and precise HPLC method with ultraviolet detection was developed and fully validated for quality 
control analysis of griseofulvin in tablets. The proposed method is very rapid, where the total analytical run time is 5.16 minute. 
) value 0.9998, slope 274.9 and intercepts 
19093. The precision study revealed that the percentage relative standard deviation was within the acceptable limit and the mean recovery was 
found to be between 98%-102%. Griseofulvin was exposed to acidic, alkaline, oxidative, thermal and photolytic stress conditions and the sample 
was taken at different time intervals. The stressed samples were analyzed by the proposed method. The proposed method can be used for routine 
analysis stability testing and assay of griseofulvin in quality control laboratories. 
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INTRODUCTION 
Griseofulvin is an antifungal drug that is administered orally. It is 
used both in animals and in humans, to treat fungal infections of the 
skin (commonly known as ringworm) and nails. It is derived from 
the mold Penicillium griseofulvum. Griseofulvin (7-chloro-2’, 4, 6-
trimethoxy-6’-methyl-Gris-2’-en-3, 4’-Dione) is primarily used to 
treat dermatophyte infections in humans and animals. Griseofulvin 
is a poorly water-soluble drug, which displays a dissolution rate-
limited absorption pattern in humans and animals. Hence, it is often 
used as a model drug to assess the influence of various 
physicochemical, physiological, and dosage form factors on the 
absorption kinetics and bioavailability of hydrophobic drugs. Its 
molecular formula is C17H17ClO6
 
. Its molecular weight is 352.766, 
and physical state is a yellowish white crystalline powder with slight 
peculiar odor. It is freely soluble in DMF, methanol, ethanol, 
practically insoluble in water. UV λ max is 291 nm in methanol [1]. 
The structure of griseofulvin shown in (fig. 1). 
 
Fig. 1: Chemical structure of griseofulvin 
 
Literature survey reveals that various analytical methods are 
present for estimation of griseofulvin with reversed-phase high-
performance liquid chromatography (RP-HPLC) [2-5], but the 
present study is the first time report on stability indicating assay of 
griseofulvin
In this method, isocratic elution method is selected for the analysis 
of 
 in the presence of degradation products by HPLC. 
griseofulvin
It gave better baseline separation and peak shape, which is suitable 
for the routine analysis of 
 because 
griseofulvin. In view of above in the 
present study, we hereby report the development and validation of a 
stability indicating isocratic reverse-phase HPLC (RP-HPLC) method 
for analysis of griseofulvin
MATERIALS AND METHODS 
 in the presence of degradation products 
as per ICH guidelines. 
Chemicals and reagents 
Griseofulvin was provided by Unichem Healthcare Ltd, Mumbai. 
Methanol was from merk Specialties Pvt. Ltd., Mumbai. Acetonitrile 
was from spectrochem Pvt. Ltd., Mumbai. 
All chemicals were at least of analytical grade and used as received. 
Purified HPLC grades water 
Was obtained by reverse osmosis and filtration through a milli-Q® 
system (Millipore, Milford, MA, USA) and was used to prepare all 
solutions. 
Instrumentation 
A Cyber lab LC 100 plus (USA) HPLC system was utilized. Separation 
was carried out on a shiseido C18, 250 mm x 4.6 mm, 5μm particle 
size column (at ambient Temperature), and isocratic run under 
reverse phase partition chromatographic condition. The equipment 
was controlled by a PC with properly installed chromatographic 
software. 
Chromatographic conditions 
The mobile phase consisted of Methanol: Water (70:30) filtered 
through 0.45 μm nylon filter and degassed in ultrasonic bath prior to 
use. The sample solutions were also filtered using 0.45μm 
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membrane filters. The mobile phase was delivered isocratic at a flow 
rate 1.0 ml/min. The injection volume was a 20μl and the total run 
time was 5.16 min. The detection was carried out at 291 nm.  
System suitability parameters 
The system suitability test is an integral part of chromatographic 
methods and used to verify that the reproducibility of the 
chromatographic system is adequate for the analysis to be 
performed. An RP-HPLC method was developed keeping in mind the 
system suitability parameters i.e. retention time, asymmetry, 
theoretical plates, and percent relative standard deviation of six 
injections were evaluated. 
Specificity 
Specificity is the ability to assess the analyte unequivocally in the 
presence of components that may be expected to be present. The 
specificity of the method was performed by injecting standard mix 
solution of griseofulvin, marketed formulation, and blank.  
Calibration curve 
Aliquots of the standard solution were diluted in a series of 10 ml 
volumetric flasks with the solvent to obtain the concentration range 
0.1-1.2 μg/ml to for griseofulvin. Calibration curve was constructed 
by plotting an area under curve against concentration. 
Forced degradation study 
To evaluate, intrinsic stability griseofulvin was subjected to force 
degradation as per International Community on Harmonization 
(ICH) guidelines to get an idea of how drug substance or product 
degrades, degenerate and behaves under changing condition, which 
helps in developing stability indicating method of analysis.  
Preparation of standard solution 
A solution of griseofulvin was prepared by accurately weighed and 
transferred about 10 mg of griseofulvin reference/working standard 
into a clean 50 ml volumetric flask, then 25 ml of solvent was added 
and sonicate for five minutes to dissolve the griseofulvin, volume 
was made up to the mark with solvent this gave a solution of 
concentration 200μg/ml. From this solution, 5 ml was pipetted out 
and transferred to a 10 ml clean volumetric flask and the volume 
was made up to the mark with solvent this result in a stock solution 
of concentration 100μg/ml. From this stock solution, 0.1 ml solution 
was pipetted out and transferred to a 10 ml clean volumetric flask 
and volume was made up with solvent this result in a standard 
solution of concentration 1μg/ml. 
Sample solution  
A sample solution of griseofulvin was prepared by accurately 
weighed and transferred powdered tablet equivalent to 10 mg drug 
into a clean 50 ml volumetric flask, 25 ml of solvent was added and 
sonicate for five minutes to dissolve the griseofulvin, volume was 
made up to the mark with solvent, this give a solution of 
concentration 200μg/ml. From this solution, 5 ml was pipetted out 
and transferred to a 10 ml clean volumetric flask and the volume 
was made up to the mark with solvent this result in a stock solution 
of concentration 100μg/ml. From this stock solution, 0.1 ml solution 
was pipette out and transferred to a 10 ml clean volumetric flask 
and volume was made up with solvent this result in a standard 
solution of concentration 1μg/ml. 
Blank solution  
Methanol: Water (70:30) was used as a blank solution (Diluent).  
Placebo solution  
Methanol: Water (70:30) was used as a placebo Solution.  
RESULTS AND DISCUSSION 
Various mobile phases were tried by permutation and combinations 
and also by varying flow rate, column temperature and types of 
buffers with varying pH and solvents. The prepared different mobile 
phases were filtered through 0.45μm membrane filter paper prior to 
use. The mobile phase composition at a ratio of 70:30 (v/v) of 
methanol and water was found to be most suitable to obtain peak of 
griseofulvin at 5.16 min is well defined and free, from tailing. 
All of the analytical validation parameters for this proposed method 
were determined according to ICH guidelines as follows [6]. 
System suitability parameter  
The optimized method developed resulted in the elution of 
griseofulvin at 5.16 min. (fig. 2) represents the typical chromatogram 
of standard griseofulvin. System suitability parameters were evaluated 
for six replicate injections of the standard at 10µg/ml. 
Limit of detection and quantification 
The detection limit (LOD) is the lowest amount of analyte in the 
sample, which can be detected but not necessarily quantified as an 
exact value. The quantification limit (LOQ) is the lowest amount of 
analyte in the sample, which can be quantitatively determined with 
suitable precision and accuracy. The LOD and LOQ are calculated as 














Fig. 2: Effect of methanol: water 
 
Table 1: Linearity results, limit of detection (LOD) and limit of quantitation (LOQ) 
Compound  r Calibration curve equation 2 LOQ(%RSD)  LOD(%RSD) 
Griseofulvin 0.9998 Y=19093X-274.92  1.1  0.7 
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Linearity 
Linearity of method was evaluated by preparing a series of 
concentrations 0.1μg/ml, 0.5μg/ml, 0.8μg/ml, 0.9μg/ml, 1 μg/ml, 
1.1μg/ml and 1.2μg/ml of griseofulvin. The solutions were analyzed in 
triplicate and measured the peak response of the analyte. Linearity 
curve was plotted; linear regression equation was found to be y= 
19093x–274.92, with a correlation coefficient of 0.9998. Linearity 
data’s are summarized and shown in table 1. The linearity curve and 
overlaid chromatograms are shown in (fig. 3) and (fig. 4). 
 
 
Fig. 3: Linearity curve of griseofulvin 
 
 
Fig. 4: Overlain chromatogram of griseofulvin 
 
Precision  
Three injections of same concentration were given on the same day, 
and these studies were also repeated on different days to determine 
inter-day precision. Assay μg/ml and RSD values obtained indicate a 
valid method. The result shown in table 2 indicates that the method 
is selective for the assay of griseofulvin without interference from 
the excipients used in these tablets. The results obtained for the 
evaluation of precision of the method are compiled in table 2. 
 
Table 2: Intra-assay precision data of proposed RP-HPLC method (Method ruggedness) 
 Assay  Mean (%w/w)  SD (N=6)  RSD (%) 
Assay-1  21590.91  203.05  0.94% 
Assay-2  21635.98 345.71  1.5% 
Intra Assay  21613.44  274.38  1.2% 
 
Table 2: Inter-assay precision data of proposed RP-HPLC method 
 Assay  Mean (%w/w)  SD (N=6)  RSD (%) 
Assay-1  21191.98  328.82  1.5% 
Assay-2  21181.48 376.48  1.7% 
Intra Assay  21186.73  352.65  1.6% 
 
Accuracy 
The accuracy of the method was carried out by recovery studies. A 
known concentration of griseofulvin was analyzed at three different 
levels (80%, 100% and 120%). Each solution was prepared in 
triplicate and analyzed in triplicate after suitable dilution. The 
recovery data obtained at each level were within 2%. The average 
recovery yield at three different levels of 80%, 100%, and 120% 
were found to be 100.3, 99.67 and 99.45 respectively. Since the 
results obtained were within the acceptable range 98.0 to 102.0%, 
the method was deemed to be accurate. The accuracy results are 
summarized in table 3. 
 
Table 3: Accuracy of griseofulvin 
 Parameters   % Taken   Mass taken (mg/1tab.) Mass found (mg/1tab.) % Recovery 
  8.1 8.00 100 
 80 8.0 7.99 99.8 
  7.9 8.00 101.2 
  10.1 9.99 99 
 100 10.0 10.00 100 
  10.0 10.00 100.01 
  12.0 11.99 99.99 
 120 12.1 12.00 99.18 
  12.1 12.00 99.19 
 X    99.81 
 SD    0.662 
 %RSD    0.663 
 
Specificity (forced degradation studies) 
Griseofulvin was allowed to hydrolyze in the base (0.1N NaOH), acid 
(0.1N HCl) and hydrogen peroxide (10 % v/v). Griseofulvin was also 
studied for its thermal degradation at 80 °C for 2 d and photolytic 
degradation for 10 d, exposed to white fluorescent light (1.2 million 
lux) near UV fluorescent light (200 w/m2
Powdered tablet equivalent to 10 mg drug was accurately weighed 
and transferred to 50 ml clean volumetric flask and volume were 
made up with 0.1N NaOH solution, 0.1N HCl and hydrogen peroxide 
10 % v/v kept at room temperature to accelerate the degradation. 5 
mL of sample was taken out at various time intervals, and it was 
neutralized with 0.1N HCl solution and 0.1N NaOH diluted with 
solvent to get the final concentration of 100μg/ml of griseofulvin. ). 
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Similarly, placebo solution was prepared. Sample and placebo 
solutions were analyzed as per methodology, calculated the 
percentage degradation. The results of stability studies are 
presented in table 4. 
 
Table 4: Forced degradation study of griseofulvin 
Test preparation  Area of griseofulvin in the test preparation  % drug remained  % drug degraded  
Control sample  22676.2  100  0 
Base Stress-4 h  20037.1  88.36  11.64 
Base Stress-8 h  13596.4  59.95  40.05 
Base Stress-24 h  9160.0  40.39  59.61 
Acid Stress-4 h  20787.0  91.66  8.34 
Acid stress-8 h  8273.6  36.48  63.52 
6% Peroxide treated-4 h  17698.4  78.04  21.96 
6% Peroxide treated-8 h  8930.9  39.38  60.62 
Heat-24 h  22435.3  98.93  1.06 
Heat-48 h  21349.3  94.14  5.86 
Light-5days  21308.9  93.97  6.03 
Light-10days  12945.5  57.08  42.92 
 
CONCLUSION 
An economical, accurate, sensitive and precise HPLC method with 
ultraviolet detection was developed and fully validated for quality 
control analysis of griseofulvin in tablets. The proposed method is 
very rapid, where the total analytical run time is 5.16 minute. 
Griseofulvin was exposed to acidic, alkaline, oxidative, thermal and 
photolytic stress conditions and the sample was taken at different 
time intervals. The stressed samples were analyzed by the proposed 
method. The proposed method can be used for routine analysis stability 
testing and assay of griseofulvin in quality control laboratories. 
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